Publication:
Can diabetes insipidus be used as a marker for multisystemic and progressive disease in langerhans cell histiocytosis?

No Thumbnail Available

Date

2021-12-01

Journal Title

Journal ISSN

Volume Title

Publisher

Kuwait Medical Assoc

Research Projects

Organizational Units

Journal Issue

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease with an yearly incidence of nine cases per a million in children and 1-2 cases per a million adults. 68.6% of LCH presented with multisystem involvement. A 40-year-old woman who was admitted to endocrinology outpatient clinic with symptoms of polyuria, polydipsia and headache was diagnosed with diabetes insipidus (DI). Desmopressin treatment was initiated, but six months after therapy, re-evaluation revealed progression in hypophyseal mass. Thoracoscopic biopsy shows LCH with multisystemic involvement. She did not respond clinically to systemic chemotherapy and external radiotherapy and died due to pneumonia.LCH should be taken into consideration in patients diagnosed with DI. DI is almost always the hallmark of hypothalamic pituitary axis involvement and a sign of multisystemic involvement.

Description

Keywords

Endocrine disorders, Diabetes insipidus, Langerhans cell histiocytosis, Multisystemic disease, Science & technology, Life sciences & biomedicine, Medicine, general & internal, General & internal medicine

Citation

Collections


Metrikler

Search on Google Scholar


Total Views

1

Total Downloads

0